Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclopofol plus nalbuphine for laryngeal mask anesthesia in day hysteroscopic surgery
ChiCTR2400079340Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Jingzhou
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol, nalbuphine and sufentanil in endometrial polyp (2 arms), sponsored by The First People's Hospital of Jingzhou. Primary endpoint: Laryngeal mask placement reaction. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
ciprofolnalbuphinesufentanil
03
Conditions
endometrial polyp
Beyond the preview
Go deeper on ChiCTR2400079340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079340.